NASDAQ$LNTH
Lantheus Holdings, Inc · Q3 2024 earnings
Q3 2024 earnings · · Investor relations
Briefing
Reported an increase in worldwide revenue and adjusted EPS, driven by strong performance of PYLARIFY and DEFINITY, and expanded its Alzheimer's disease radiodiagnostics portfolio.
Lantheus reported a strong Q3 2024 with an 18.4% increase in worldwide revenue to $378.7 million. GAAP EPS was $1.79, while adjusted EPS was $1.70. The company is narrowing its full-year 2024 revenue and EPS guidance towards the higher end of previous estimates.
- Worldwide revenue increased by 18.4% to $378.7 million compared to Q3 2023.
- PYLARIFY sales increased by 20.6% to $259.8 million, driven by increasing volumes at existing accounts.
- DEFINITY sales increased by 14.3% to $77.0 million, driven by market growth and competitor supply challenges.
- GAAP fully diluted earnings per share decreased to $1.79, while adjusted fully diluted earnings per share increased by 15.6% to $1.70.
Headline financials
Revenue & EPS history
Lantheus · Revenue · Quarterly
$379M
Revenue by segment
Lantheus · $76.9M total across 2 segments · Q3 2020
- DEFINITY$55.4M—72.1%
- TechneLite$21.5M—27.9%
Forward guidance
The company narrows full year 2024 revenue and fully diluted earnings per share guidance towards higher end of the previously issued guidance.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2024
+4.2%
Avg return
Earnings day
+5.2%
Avg return
5 days after
+10.2%
Avg return
30 days after
51%
23 / 45 earnings
Positive
+63.0%
Q2 2016
Best reaction
-23.2%
Q3 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +5.6% | +11.7% | +17.2% | |
| Q4 2025 | -0.4% | +4.1% | -1.7% | |
| Q3 2025 | -6.2% | -6.7% | +10.6% | |
| Q1 2025 | -23.1% | -24.2% | -22.2% | |
| Q4 2024 | +16.5% | +18.5% | +20.1% | |
| Q3 2024 | -23.2% | -26.9% | -22.6% | |
| Q2 2024 | -10.2% | -9.8% | -3.0% | |
| Q1 2024 | +12.1% | +12.8% | +21.4% | |
| Q4 2023 | +16.9% | +20.4% | +4.1% | |
| Q3 2023 | -2.7% | -1.6% | +11.7% | |
| Q2 2023 | -7.5% | -13.9% | -17.7% | |
| Q1 2023 | +14.0% | +17.9% | +7.5% | |
| Q4 2022 | +24.3% | +27.0% | +39.8% | |
| Q3 2022 | -12.0% | -17.2% | -11.1% | |
| Q2 2022 | +3.5% | +5.1% | +3.4% | |
| Q1 2022 | +11.6% | +12.7% | +19.0% | |
| Q4 2021 | +61.6% | +70.3% | +72.9% | |
| Q3 2021 | +16.6% | +21.5% | +6.9% | |
| Q2 2021 | +7.5% | +6.5% | +2.1% | |
| Q1 2021 | -5.7% | -7.2% | +3.7% | |
| Q4 2020 | -5.0% | -6.9% | +0.7% | |
| Q3 2020 | +0.3% | +7.6% | +22.2% | |
| Q2 2020 | -14.2% | -19.4% | -14.1% | |
| Q1 2020 | -14.0% | -9.4% | -2.1% | |
| Q4 2019 | +1.2% | -3.5% | -21.7% | |
| Q3 2019 | +4.1% | +6.4% | +4.9% | |
| Q2 2019 | -21.3% | -19.9% | -24.2% | |
| Q1 2019 | -5.1% | +3.8% | -1.0% | |
| Q4 2018 | +18.8% | +29.1% | +35.4% | |
| Q3 2018 | +10.2% | +18.8% | +40.8% | |
| Q2 2018 | -7.6% | -6.6% | +11.4% | |
| Q1 2018 | -2.5% | -14.7% | -20.4% | |
| Q4 2017 | -22.5% | -17.2% | -21.0% | |
| Q3 2017 | +19.3% | +17.9% | +16.8% | |
| Q2 2017 | -16.0% | -6.8% | -5.1% | |
| Q1 2017 | +13.1% | +1.5% | +25.0% | |
| Q4 2016 | +28.6% | +33.9% | +25.9% | |
| Q3 2016 | +9.8% | +1.7% | +6.4% | |
| Q2 2016 | +63.0% | +63.9% | +155.4% | |
| Q1 2016 | -6.2% | — | — | |
| Q1 2015 | -6.2% | — | — | |
| Q4 2015 | +17.1% | — | — | |
| Q3 2015 | +27.6% | — | — | |
| Q4 2014 | -1.3% | — | — | |
| Q2 2015 | -1.3% | — | — | |
| Q2 2014 | — | — | — | |
| Q4 2013 | — | — | — | |
| Q3 2013 | — | — | — | |
| Q2 2013 | — | — | — | |
| Q4 2012 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro